Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.20
-0.12 (-1.06%)
Sep 8, 2026, 9:30 AM EDT - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $222.06 million as of September 8, 2026. Its market cap has decreased by -64.93% in one year.
Market Cap
222.06M
Enterprise Value
-19.82M
1-Year Change
-64.93%
Ranking
Category
Stock Price
$11.20
ChartMarket Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has decreased from $385.32M to $222.06M, a decrease of -42.37%. That is a compound annual growth rate of -8.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 222.06M | -64.20% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Greenwich LifeSciences | 234.12M |
| Protara Therapeutics | 232.84M |
| Acumen Pharmaceuticals | 229.97M |
| Sol-Gel Technologies | 227.61M |
| Tonix Pharmaceuticals Holding | 225.36M |
| AN2 Therapeutics | 222.27M |
| Coherus Oncology | 219.39M |
| Armata Pharmaceuticals | 217.14M |